Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
Clinical trial NCT04409639 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04409639
- Sponsor
- University of Utah
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2026-01-02
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.